Roberto Cauda

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 12

Top Topics

Randomized Controlled Trial

Infectious Diseases

Top Venues

Antibiotics (Basel, Switzerland)

HIV research & clinical practice

Journal of chemotherapy (Florence, Italy)

This page only lists publications with an associated author ORCID identifier.

Publications

Cristiana Barbati, Carla Bromuro, Silvia Vendetti, Antonella Torosantucci, Roberto Cauda, Antonio Cassone, Carla Palma
The Glycan Ectodomain of SARS-CoV-2 Spike Protein Modulates Cytokine Production and Expression of CD206 Mannose Receptor in PBMC Cultures of Pre-COVID-19 Healthy Subjects. Viruses 16 (4) (2024)
Cristiana Barbati, Carla Bromuro, Silvia Vendetti, Antonella Torosantucci, Roberto Cauda, Antonio Cassone, Carla Palma
The Glycan Ectodomain of SARS-CoV-2 Spike Protein Modulates Cytokine Production and Expression of CD206 Mannose Receptor in PBMC Cultures of Pre-COVID-19 Healthy Subjects. Viruses 16 (4) (2024)
Cristiana Barbati, Carla Bromuro, Silvia Vendetti, Antonella Torosantucci, Roberto Cauda, Antonio Cassone, Carla Palma
The Glycan Ectodomain of SARS-CoV-2 Spike Protein Modulates Cytokine Production and Expression of CD206 Mannose Receptor in PBMC Cultures of Pre-COVID-19 Healthy Subjects. Viruses 16 (4) (2024)
Cristiana Barbati, Carla Bromuro, Silvia Vendetti, Antonella Torosantucci, Roberto Cauda, Antonio Cassone, Carla Palma
The Glycan Ectodomain of SARS-CoV-2 Spike Protein Modulates Cytokine Production and Expression of CD206 Mannose Receptor in PBMC Cultures of Pre-COVID-19 Healthy Subjects. Viruses 16 (4) (2024)
Stefano Pascarella, Martina Bianchi, Marta Giovanetti, Domenico Benvenuto, Alessandra Borsetti, Roberto Cauda, Antonio Cassone, Massimo Ciccozzi
The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants. Pathogens (Basel, Switzerland) 11 (7) (2022)
Augusto Di Castelnuovo, Simona Costanzo, Antonio Cassone, Roberto Cauda, Giovanni de Gaetano, Licia Iacoviello
Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials. Pathogens and global health 115 (7-8) (2021)
Stefano Pascarella, Massimo Ciccozzi, Martina Bianchi, Domenico Benvenuto, Marta Giovanetti, Roberto Cauda, Antonio Cassone
Shortening Epitopes to Survive: The Case of SARS-CoV-2 Lambda Variant. Biomolecules 11 (10) (2021)
Rita Murri, Claudia Palazzolo, Francesca Giovannenze, Francesco Taccari, Marta Camici, Teresa Spanu, Brunella Posteraro, Maurizio Sanguinetti, Roberto Cauda, Massimo Fantoni
Day 10 Post-Prescription Audit Optimizes Antibiotic Therapy in Patients with Bloodstream Infections. Antibiotics (Basel, Switzerland) 9 (8) (2020)
Antonio Cassone, Licia Iacoviello, Roberto Cauda
Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients. Future microbiology 15 (2020)
Francesca Lombardi, Simone Belmonti, Alberto Borghetti, Arturo Ciccullo, Gianmaria Baldin, Roberto Cauda, Massimiliano Fabbiani, Simona Di Giambenedetto
Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients. HIV research & clinical practice (2019)
Caroline Charlier, Ingólfur Johannessen, Claire L Mackintosh, David Wilks, Roberto Cauda, Federica I Wolf, Claire Le Jeunne
International infectious diseases teaching to undergraduate medical students: A successful European collaborative experience. Medical teacher 39 (9) (2017)
Roberta Gagliardini, Massimiliano Fabbiani, Manuela Colafigli, Alessandro D'Avino, Annalisa Mondi, Alberto Borghetti, Silvia Lamonica, Roberto Cauda, Andrea De Luca, Simona Di Giambenedetto
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients. Journal of chemotherapy (Florence, Italy) 29 (5) (2016)